Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c64564104466314f1469f26705ca5a1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_997f32fa88ac09ebc096681a2e000fd3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b4e252b36f75d1a531924df23a2bb31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d64153e243152e5f255d74bb64a4c0e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_99d5a1f03c280a68b1a17ea3149fa7e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b66b86852b9a10dfa413d7b0188704cf http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4a13006b1ba46bb813c7096ab333514c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0db8d5ba550b09fbe2909ed025364fb0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bde8af89077748104364fdd51f0989e7 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-555 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-20 |
filingDate |
2007-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e025752d9ab1a3cbea1656d19ec518e1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6066e8448b602ca798ea55420410f5e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_075db26d74cca4a93c925cc1793dae7c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f30519ee3ba9ada59ff74485d5b803c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7cdc59567405cac5954d128eae7c34a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c9a6cfed88c2009994e0d30ba800d6b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7df3e824d89aaf68065fb7e1d5210612 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d00f808b9e1a5899c35fd492293cac5 |
publicationDate |
2008-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2008154719-A1 |
titleOfInvention |
Recombinant human interferon-like proteins |
abstract |
This application relates to recombinant human interferon-like proteins. In one embodiment a recombinant protein created by gene shuffling technology is described having enhanced anti-viral and anti-proliferative activities in comparison to naturally occurring human interferon alpha 2b (HuIFN-α2b). The invention encompasses a polynucleotide encoding the protein and recombinant vectors and host cells comprising the polynucleotide. Preferably the polynucleotide is selected from the group of polynucleotides each having a sequence at least 93% identical to SEQ ID: No. 1 and the protein is selected from the group of proteins each having an amino acid sequence at least 85% identical to SEQ ID No: 2. The proteins and compositions comprising the proteins can be used for treatment of conditions responsive to interferon therapy, such as viral diseases and cancer. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7867482-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7868151-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9982028-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8425895-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10538565-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9234022-B2 |
priorityDate |
2007-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |